TFF Pharmaceuticals Entered Into An At Market Offering Agreement With H.C. Wainwright & Co., LLC
Portfolio Pulse from Benzinga Newsdesk
TFF Pharmaceuticals has entered into an At Market Offering Agreement with H.C. Wainwright & Co., LLC, as per an SEC filing.
May 17, 2024 | 8:19 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
TFF Pharmaceuticals has entered into an At Market Offering Agreement with H.C. Wainwright & Co., LLC, which could lead to potential dilution of shares.
The At Market Offering Agreement allows TFF Pharmaceuticals to issue new shares, which could dilute the value of existing shares and potentially lead to a short-term decrease in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100